Pressroom: Media Coverage

Showing 421 - 440 of 555 news items

2011

Brain Changes Seen in Breast-Cancer Survivors

Neuropsychologist James Root explained a common phenomenon called “chemo brain” or “chemo fog,” a phrase many cancer survivors use to describe losses in mental sharpness or altered mental function after cancer treatment.

November 15, 2011
A Conversation with Craig B. Thompson, MD

To mark the one-year anniversary of his tenure, President and CEO of Memorial Sloan Kettering Craig Thompson talked about recent discoveries and the challenges that remain in advancing better targeted treatments for difficult-to-treat cancers. Therapies pioneered at Memorial Sloan Kettering by Paul Chapman and James Allison, as well as research led by Renier Brentjens, were discussed.

November 15, 2011
Remembering Evelyn Lauder

Larry Norton, Medical Director of the Evelyn H. Lauder Breast Center, mourned the loss of Evelyn H. Lauder, a tireless cancer research advocate and a member of Memorial Sloan Kettering’s Board of Overseers.

November 12, 2011
Breast Reconstruction May Quickly Improve Quality of Life

Plastic surgeon Andrea Pusic used a questionnaire she developed, with support from the American Society of Plastic Surgeons, called the BREAST-Q, to assess patient satisfaction and quality of life after breast reconstruction. Results showed that women who underwent breast reconstruction after a mastectomy using their own abdominal tissue felt better about themselves as early as three weeks later.

November 11, 2011
Human Stem Cells Treat Parkinson’s in Mice

New research published in Nature by Sloan Kettering Institute developmental biologist Lorenz Studer describes how stem cells from human embryos were used to successfully treat Parkinson’s disease in mice and rats. “We see a real opportunity to develop this into an actual cell therapy for patients,” he told the Wall Street Journal.

November 7, 2011
Suicide Switch May Pave Way for Safer Cancer Treatment, Researchers Find

An editorial by Sloan Kettering Institute cell researcher Michel Sadelain responds to new research reported in the New England Journal of Medicine on a novel system to shut down cell therapies if their intended use goes awry. The approach could possibly help cut down on side effects from stem cell and other cell-based treatments. “The issue is that cells are complex living things and sometimes they do something we don’t want,” Sadelain told Bloomberg.com.

November 3, 2011
Ovarian Cancer Research Previewed

Updates on ovarian cancer clinical trial results and findings on cause and treatment were presented by Memorial Sloan Kettering gynecologic pathologist Robert Soslow, gynecologist and geneticist Noah Kauff, gynecologic oncologist Paul Sabbatini, and others at the ‘Advances in Ovarian Cancer’ meeting in Dublin, Ireland.

November 3, 2011
ASCO Report: Accelerating Progress Against Cancer

Thoracic oncologist Mark Kris, who helped to co-author the American Society of Clinical Oncology (ASCO) plan for transforming clinical cancer research and speeding the creation of new therapies for patients, is cited in this story about a new road map for cancer treatment.

November 3, 2011
National Research Council Panel Calls for Google Maps of Human Disease

Charles Sawyers, co-chair of the National Research Council panel that has called for the creation of a massive data network that would combine cutting-edge genomic and molecular data on patients' diseases with their routine medical records, told Science Magazine and others at a briefing that while modest efforts like this already exist, "We want to do it on a bigger scale." Sawyers is Chair of Memorial Sloan Kettering's Human Oncology & Pathogenesis Program (HOPP).

November 2, 2011
Study Weakens Case for Preventive Mastectomy

Medical oncologist Mark Robson comments to the Wall Street Journal on findings published in the Journal of Clinical Oncology reporting that women with mothers and sisters who carry one of the BRCA gene mutations but who aren't carriers themselves don't have an especially heightened risk of breast cancer. Robson and medical oncologist Andrew Seidman were also quoted in MedPage Today, with Seidman expressing hope that the findings would cut down on "unwarranted and excessive screening and/or risk-reducing interventions."

November 1, 2011
One Father's Special Reason to Run

Pediatric neurologist Kevin De Braganca was interviewed about his patient, Ty Campbell, whose father and aunt are running the NYC marathon for Fred's Team.

October 28, 2011
From Unknown Cancer Gene to Potential Cancer Drug

Cancer biology and genetics research fellow Elisa Oricchio has identified a gene – EPHA7 – whose loss can lead to a sluggish but hard-to-treat type of lymphoma called follicular lymphoma.

October 27, 2011
Creator of Patient Navigators to Help the Disadvantaged Visits St. Louis

The Breast Examination Center of Harlem’s Harold Freeman pioneered the system of personal care and service provided by patient navigators to prevent sick people and poor people from falling through the cracks in healthcare delivery.

October 27, 2011
Monoclonal Gammopathy of Undetermined Significance (MGUS): Questions About Symptoms, Related Diseases

Hematologist-oncologist Hani Hassoun answers questions about MGUS, a blood disorder that can be a precursor to the cancer, multiple myeloma.

October 27, 2011
Is This the End of Popping Vitamins?

Hematologist-oncologist Mark Heaney discusses recent studies that suggest multivitamins and many other dietary supplements often don’t have health benefits — and in some cases may even cause harm.

October 25, 2011
'It's Surprisingly Liberating Not To Have Hair'

Seventeen-year-old Ella Landesberg has been chronicling the ups and downs of her experience battling acute lymphoblastic leukemia on her blog. Pediatric hematologist-oncologist Peter Steinherz explains the disease.

October 25, 2011
Mammogram's Role as Savior Is Tested

Epidemiologist Colin Begg discusses a new analysis published in the Archives of Internal Medicine that offers a stark reality check about the value of mammography screening.

October 24, 2011
Copper-Coated Era Beckons for Hospitals

As part of a national study on the effectiveness of copper as an antimicrobial surface, Memorial Sloan Kettering was one of several U.S. hospitals to temporarily install copper-coated equipment surfaces in some intensive care units. Investigator and infectious disease specialist Kent Sepkowitz is quoted.

October 21, 2011
Femara May Beat Tamoxifen at Preventing Breast Cancer's Return

Medical oncologist Maura Dickler discusses new research that found that the breast cancer drug letrozole, marketed as Femara, may be more effective than tamoxifen at preventing the return of breast cancer and improving survival among older women with hormone-sensitive breast cancers.

October 21, 2011
Radiation Plus Surgery Cuts Risk of Breast Cancer Return

Medical oncologist Elizabeth Comen discusses new research that shows that adding radiation therapy to breast-conserving surgery halves the chance that cancer will come back and reduces the risk of dying from breast cancer, when compared to the breast-conserving surgery alone.

October 20, 2011